Cargando…
Novel Opipramol-Baclofen Combination Alleviates Depression and Craving and Facilitates Recovery From Substance Use Disorder—An Animal Model and a Human Study
Substance use disorders (SUDs) are associated with depression and anxiety, with the latter being one of the major factors in substance-seeking and relapse. Due to dose-dependent sedative side effects there is limited efficacy of baclofen treatment for SUDs. Here we suggest the use of a novel combina...
Autores principales: | Bareli, Tzofnat, Ahdoot, Hadas Levi, Ben Moshe, Hila, Barnea, Royi, Warhaftig, Gal, Gispan, Iris, Maayan, Rachel, Rosca, Paola, Weizman, Abraham, Yadid, Gal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733380/ https://www.ncbi.nlm.nih.gov/pubmed/35002647 http://dx.doi.org/10.3389/fnbeh.2021.788708 |
Ejemplares similares
-
The Effect of Dehydroepiandrosterone Treatment on Neurogenesis, Astrogliosis and Long-Term Cocaine-Seeking Behavior in a Cocaine Self-Administration Model in Rats
por: Ahdoot-Levi, Hadas, et al.
Publicado: (2021) -
Erratum: Novel Opipramol-Baclofen Combination Alleviates Depression and Craving and Facilitates Recovery From Substance Use Disorder—An Animal Model and a Human Study
por: Frontiers Production Office,
Publicado: (2022) -
RNA editing of the 5-HT2C receptor in the central nucleus of the amygdala is involved in resilience behavior
por: Warhaftig, Gal, et al.
Publicado: (2021) -
Modulation of Mood States as a Major Factor in Relapse to Substance Use
por: Yadid, Gal, et al.
Publicado: (2012) -
A DNA Methylation Signature of Addiction in T Cells and Its Reversal With DHEA Intervention
por: Lax, Elad, et al.
Publicado: (2018)